Evidence supporting the occurrence of these cellular events came from the observation that administration of an Ab that blocks CXCL9/CXCL10-CXCR3 interaction prevented migration of IFN-γ–producing Th1 cells into the pancreas and indeed, such Ab administration impeded the development of experimental AIP. Here, CXCL10 is linked to autoimmune pancreatitis.